Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - valsartan; hydrochlorothiazide - film-coated tablet - 160 mg /12.5 milligram(s) - angiotensin ii antagonists and diuretics; valsartan and diuretics

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - amlodipine; valsartan - film-coated tablet - 5/80 milligram(s) - angiotensin ii antagonists and calcium channel blockers; valsartan and amlodipine

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - amlodipine; valsartan - film-coated tablet - 5/160 milligram(s) - angiotensin ii antagonists and calcium channel blockers; valsartan and amlodipine

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - amlodipine; valsartan - film-coated tablet - 10/160 milligram(s) - angiotensin ii antagonists and calcium channel blockers; valsartan and amlodipine

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - amlodipine; valsartan - film-coated tablet - 5mg/80 milligram(s) - angiotensin ii antagonists and calcium channel blockers; valsartan and amlodipine

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - amlodipine; valsartan - film-coated tablet - 5mg/160 milligram(s) - angiotensin ii antagonists and calcium channel blockers; valsartan and amlodipine

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - amlodipine; valsartan - film-coated tablet - 10mg/160 milligram(s) - angiotensin ii antagonists and calcium channel blockers; valsartan and amlodipine

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288), benazepril hydrochloride (unii: n1sn99t69t) (benazeprilat - unii:jrm708l703) - amlodipine 2.5 mg - amlodipine and benazepril hydrochloride capsules are indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent. - do not coadminister aliskiren with angiotensin receptor blockers (arbs), ace inhibitors, including amlodipine besylate and benazepril hydrochloride in patients with diabetes. - amlodipine and benazepril hydrochloride capsules are contraindicated in patients with a history of angioedema, with or without previous ace inhibitor treatment, or patients who are hypersensitive to benazepril, to any other ace inhibitor, to amlodipine, or to any of the excipients of amlodipine and benazepril hydrochloride capsules. - amlodipine and benazepril hydrochloride capsules are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). do not administer amlodipine and benazepril hydrochloride capsules within 36 hours of switching to or from a neprilysin inhibitor, e.g., sacubitril/valsartan [see warnings and precautions (5.1) ]. pregnancy

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288), benazepril hydrochloride (unii: n1sn99t69t) (benazeprilat - unii:jrm708l703) - amlodipine 5 mg - amlodipine and benazepril hydrochloride capsules are indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent. - do not coadminister aliskiren with angiotensin receptor blockers (arbs), ace inhibitors, including amlodipine besylate and benazepril hydrochloride in patients with diabetes. - amlodipine and benazepril hydrochloride capsules are contraindicated in patients with a history of angioedema, with or without previous ace inhibitor treatment, or patients who are hypersensitive to benazepril, to any other ace inhibitor, to amlodipine, or to any of the excipients of amlodipine and benazepril hydrochloride capsules. - amlodipine and benazepril hydrochloride capsules are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). do not administer amlodipine and benazepril hydrochloride capsules within 36 hours of switching to or from a neprilysin inhibitor, e.g., sacubitril/valsartan [ see warnings and precautions ( 5.1) ]. pregnan

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288), valsartan (unii: 80m03yxj7i) (valsartan - unii:80m03yxj7i), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - amlodipine 10 mg - exforge hct (amlodipine, valsartan, hydrochlorothiazide) is indicated for the treatment of hypertension. this fixed combination drug is not indicated for the initial therapy of hypertension [see dosage and administration (2)]. because of the hydrochlorothiazide component, exforge hct is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. pregnancy category d valsartan, like other drugs that act on the renin angiotensin system, can cause fetal and neonatal morbidity and death when used during the second or third trimester of pregnancy. if exforge hct is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. angiotensin ii receptor antagonists, like valsartan, and angiotensin converting enzyme (ace) inhibitors exert similar effects on the renin-angiotensin system. in several dozen published cases, ace inhibitor use during the second and third trimesters of pregnancy was as